TotalMarketCap

SpyGlass Pharma

SGPNasdaq United StatesHealth CareMedical/Dental Instruments

Market cap

$1.143 B

$34.17 -0.81%

Close of 6 Nov 2026

As of 6 Nov 2026, SpyGlass Pharma (SGP) has a market capitalization of $1.14B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$39.9M

Loss-making

Shares outstanding

33,447,979

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Medical/Dental Instruments, ranked by market cap

All 124 →
  1. #35AlphatecATEC$1.22B
  2. #36PROCEPT BioRoboticsPRCT$1.16B
  3. #37SpyGlass PharmaSGP$1.14B
  4. #38Integra LifesciencesIART$1.10B
  5. #39Si-BoneSIBN$1.09B

What if SpyGlass Pharma were worth as much as…

Open the what-if tool →

Gold $28.2T

$844,202.69

Per share 24,706× higher

Bitcoin $1.53T

$45,678.34

Per share 1,337× higher

Apple $5.02T

$149,957.72

Per share 4,389× higher

Or at a round number

$2.00B$5.00B$10.0B$20.0B

Where these numbers come from

Share counts and financials for SpyGlass Pharma are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.